![Jason O’Byrne](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jason O’Byrne
Finansdirektör/CFO på
OLEMA PHARMACEUTICALS, INC.
Förmögenhet: 326 742 $ per 2026-07-31
Profil
Jason V.
O’Byrne is currently Chief Financial & Accounting Officer at Olema Pharmaceuticals, Inc. since 2026.
Formerly, Mr. O’Byrne was Chief Financial Officer & Executive Vice President at Vir Biotechnology, Inc. from 2024 to 2026, Chief Financial & Accounting Officer at Caribou Biosciences, Inc. from 2021 to 2024, Senior Vice President-Finance at Astellas Gene Therapies, Inc. from 2019 to 2021, Regional Controller at General Chemical Corp.
from 2002 to 2005, and Regional Head-Commercial Finance APAC at Genentech, Inc. Education includes an undergraduate degree from the University of British Columbia and an MBA from The Leonard N Stern School of Business.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
VIR BIOTECHNOLOGY, INC. 0,02 % | 2026-03-31 | 37 730 ( 0,02 % ) | 326 742 $ | 2026-07-31 |
Aktiva positioner av Jason O’Byrne
| Företag | Position | Start |
|---|---|---|
| OLEMA PHARMACEUTICALS, INC. | Finansdirektör/CFO | 2026-08-11 |
Tidigare kända positioner av Jason O’Byrne
| Företag | Position | Slut |
|---|---|---|
| VIR BIOTECHNOLOGY, INC. | Finansdirektör/CFO | 2026-08-03 |
| CARIBOU BIOSCIENCES, INC. | Finansdirektör/CFO | 2024-09-27 |
| AUDENTES THERAPEUTICS, INC. | Finansdirektör/CFO | 2021-02-01 |
General Chemical Corp.
 General Chemical Corp. Industrial SpecialtiesProcess Industries Manufactures and supplies metal lubricant products | Företagsledare/Principal | 2005-01-01 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Företagsledare/Principal | - |
Jason O’Byrnes utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
61
Första gradens relationer
8
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 8 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Caribou Biosciences, Inc.
 Caribou Biosciences, Inc. BiotechnologyHealth Technology Develops technology-based solutions for cellular engineering and analysis | Health Technology |
University of British Columbia
 University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
General Chemical Corp.
General Chemical Corp. Industrial SpecialtiesProcess Industries Manufactures and supplies metal lubricant products | Process Industries |
Astellas Gene Therapies, Inc.
 Astellas Gene Therapies, Inc. BiotechnologyHealth Technology Develops and commercializes gene therapy products for patients with serious rare diseases | Health Technology |
The Leonard N Stern School of Business
 The Leonard N Stern School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vir Biotechnology, Inc.
 Vir Biotechnology, Inc. BiotechnologyHealth Technology Develops cures and treatments drug for viral & bacterial diseases | Health Technology |
Olema Pharmaceuticals, Inc.
 Olema Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for the treatment & prevention of estrogen receptor positive breast cancer | Health Technology |
